Antagonistic Interplay between MicroRNA-155 and IL-10 during Lyme Carditis and Arthritis.

Area of Science:

• Immunology
• Molecular Biology
• Infectious Diseases

Background:

• MicroRNA-155 (miR-155) promotes immune activation and inflammation.
• Interleukin-10 (IL-10) is a key anti-inflammatory cytokine that suppresses miR-155.
• Lyme disease, caused by Borrelia burgdorferi, involves arthritis and carditis, with IL-10 playing a role in disease severity.

Purpose of the Study:

• To investigate the in vivo interplay between IL-10 and miR-155 in the context of Borrelia burgdorferi infection.
• To determine the specific roles of IL-10 and miR-155 in the pathogenesis of Lyme arthritis and carditis.
• To elucidate how the balance between IL-10 and miR-155 influences host defense and immune activation.

Main Methods:

• Utilized a murine model of Borrelia burgdorferi infection.
• Employed wild-type, miR-155 knockout, IL-10 knockout, and double-knockout mice.
• Analyzed immune cell activity, cytokine production, antibody responses, bacterial load, and disease severity (arthritis and carditis) in different genetic backgrounds.

Main Results:

• miR-155 was upregulated in joints of severely arthritic IL-10 deficient mice and in hearts of infected mice.
• IL-10 and miR-155 exhibited opposing, compensatory effects on immune responses.
• Both IL-10 and miR-155 were necessary for suppressing Lyme carditis, with their absence leading to severe cardiac inflammation.
• miR-155 had minimal impact on Lyme arthritis severity.
• Tissue-specific differences in pathogenesis were observed between Lyme arthritis and carditis.

Conclusions:

• The antagonistic interplay between IL-10 and miR-155 is vital for balancing host defense and immune activation, particularly in suppressing Lyme carditis.
• IL-10-mediated regulation of miR-155 is critical for maintaining healthy immunity.
• These findings reveal important tissue-specific immune dynamics in Lyme disease pathogenesis.